Millions Logo
home>US Stocks>Amdocs
$44.11$-39.85 (-47.47%)in 1 year
As on 13 Nov 2026 at 02:29NASDAQ
52 Week Low: $39.9652 Week High: $85.63

Amdocs Share Price Today

Amdocs opened at $43.14, in line with its previous close of $43.12. In the last trading session, the stock traded between $42.72 and $44.79. It showed an upward intraday trend.

Return calculator

Time Period

An investment of $100 made 5 years ago in Amdocs is now worth

$ 58.62

Resulting in a loss of

$ 41.38 (41.38%)

Invest with $1

Note: Past profits do not guarantee future returns.

Analyst Overview

Buy

Rating from 2 Analysts

Buy
50%
Hold
50%
Sell
0%

Markets Today

Today's Change

+$0.99 (+2.29%)

Day High

$44.79

Day Low

$42.72

Day Open

$43.14

Prev Close

$43.12

Volume

20,76,409

1W Return

0.99%

1M Return

-24.93%

3M Return

-23.24%

6M Return

-29.51%

1Y Return

-47.47%

Fundamentals

Market Cap ($ Mn)

4,745

PE Ratio

14.94

PB Ratio

2.00

PEG Ratio

96.10

ROE

16.40%

ROCE

14.79%

EPS (TTM)

$0.60

Investment Returns

1 Week

0.99%

1 Month

-24.93%

3 Months

-23.24%

6 Months

-29.51%

9 Months

-37.03%

Financials

Quarterly
All values in $ Mn
1.1K

Mar 25
1.1K

Jun 25
1.2K

Sep 25
1.2K

Dec 25
1.2K

Mar 26
1.2K

Jun 26

Updates

11Nov

Amdocs shares fall 30% amid T-Mobile dispute and legal probe

Shares fell 30.07% to $43.66 after T-Mobile dispute disclosures. Fiscal 2027 revenue guidance cut by 14.3% to 17.9% YoY. Ten law firms investigating potential securities fraud claims. T-Mobile accounted for 19.9% of fiscal 2025 revenue.

Yesterday
4Nov

Amdocs shares fall 39% as Q4 EPS misses, FY27 guidance cut

Shares fell 39.1% to $38.00 in pre-market trading. Q4 adjusted EPS of $1.98 missed consensus estimate of $1.99. FY27 non-GAAP EPS guided down 26-30% due to T-Mobile dispute. Quarterly sales of $1.194 billion missed estimates by 0.06%.

8 days ago
4Nov

Oppenheimer downgrades Amdocs to Perform

Oppenheimer analyst Timothy Horan downgraded Amdocs. Rating changed from Outperform to Perform. No specific financial drivers disclosed for the downgrade.

8 days ago
4Nov

Amdocs FY27 guidance: Adj EPS $5.19-$5.48 vs $8.08 est

Amdocs guides FY27 adjusted EPS to $5.19-$5.48, missing the $8.08 analyst estimate. Revenue guidance set at $3.856B-$4.025B, below the $4.845B consensus. GAAP diluted EPS projected at $3.51-$3.88, down 25% to 17% YoY. Both adjusted and GAAP metrics signal significant profit contraction.

9 days ago
4Nov

Amdocs Q1 Results: Adj EPS guided $1.27-$1.33 vs $1.94 est

Amdocs guides Q1 adjusted EPS of $1.27-$1.33 vs $1.94 analyst estimate. Sales projected at $955M-$995M against $1.199B consensus. GAAP EPS guided at $0.81-$0.89 vs $1.71 estimate. Guidance indicates significant deviation from market expectations.

9 days ago
4Nov

Amdocs expands Globe deal to modernize core telecom systems

Amdocs signs expanded multi-year deal with Globe Telecom. Agreement focuses on modernizing Globe's core systems. Follows completion of data modernization on Google Cloud. Financial terms of the new expansion are not disclosed.

9 days ago

Similar Stocks

StockLTPChange %Market CapPE
$521.13-2.26%$38,69,975.87M28.61
$172.40+2.12%$3,97,675.94M160.64
$128.38+8.82%$3,88,187.23M25.87
$234.10+0.15%$2,87,592.79M28.43
$334.47+2.49%$2,73,854.67M323.12
$248.22+1.51%$2,34,597.93M20.94
$229.06+1.46%$2,34,542.55M3,970.91
$149.26+1.81%$1,80,374.29M103.31
$218.01+2.12%$1,79,422.23M23.42
$253.66-1.88%$1,49,846.35M15.14
$70.68+0.90%$1,44,321.35M17.29
$306.36+0.30%$1,20,938.37M26.28